Barclays »

Kinnate Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 15k 2.40
2023-09-30 $21k 15k 1.44
2023-06-30 $44k 15k 3.02
2023-03-31 $183k 29k 6.23
2022-12-31 $149k 24k 6.11
2022-09-30 $185k 15k 11.99
2022-06-30 $197k 16k 12.59